Cargando…

Angiogenin and Osteoprotegerin are type II muscle specific myokines protecting pancreatic beta-cells against proinflammatory cytokines

Tissue cross-talk is emerging as a determinant way to coordinate the different organs implicated in glucose homeostasis. Among the inter-organ communication factors, muscle-secreted myokines can modulate the function and survival of pancreatic beta-cells. Using primary human myotubes from soleus, va...

Descripción completa

Detalles Bibliográficos
Autores principales: Rutti, Sabine, Dusaulcy, Rodolphe, Hansen, Jakob S., Howald, Cédric, Dermitzakis, Emmanouil T., Pedersen, Bente K., Pinget, Michel, Plomgaard, Peter, Bouzakri, Karim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030123/
https://www.ncbi.nlm.nih.gov/pubmed/29968746
http://dx.doi.org/10.1038/s41598-018-28117-2
_version_ 1783337083615576064
author Rutti, Sabine
Dusaulcy, Rodolphe
Hansen, Jakob S.
Howald, Cédric
Dermitzakis, Emmanouil T.
Pedersen, Bente K.
Pinget, Michel
Plomgaard, Peter
Bouzakri, Karim
author_facet Rutti, Sabine
Dusaulcy, Rodolphe
Hansen, Jakob S.
Howald, Cédric
Dermitzakis, Emmanouil T.
Pedersen, Bente K.
Pinget, Michel
Plomgaard, Peter
Bouzakri, Karim
author_sort Rutti, Sabine
collection PubMed
description Tissue cross-talk is emerging as a determinant way to coordinate the different organs implicated in glucose homeostasis. Among the inter-organ communication factors, muscle-secreted myokines can modulate the function and survival of pancreatic beta-cells. Using primary human myotubes from soleus, vastus lateralis and triceps brachii muscles, we report here that the impact of myokines on beta-cells depends on fiber types and their metabolic status. We show that Type I and type II primary myotubes present specific mRNA and myokine signatures as well as a different sensitivity to TNF-alpha induced insulin resistance. Finally, we show that angiogenin and osteoprotegerin are triceps specific myokines with beta-cell protective actions against proinflammatory cytokines. These results suggest that type I and type II muscles could impact insulin secretion and beta-cell mass differentially in type 2 diabetes through specific myokines secretion.
format Online
Article
Text
id pubmed-6030123
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-60301232018-07-11 Angiogenin and Osteoprotegerin are type II muscle specific myokines protecting pancreatic beta-cells against proinflammatory cytokines Rutti, Sabine Dusaulcy, Rodolphe Hansen, Jakob S. Howald, Cédric Dermitzakis, Emmanouil T. Pedersen, Bente K. Pinget, Michel Plomgaard, Peter Bouzakri, Karim Sci Rep Article Tissue cross-talk is emerging as a determinant way to coordinate the different organs implicated in glucose homeostasis. Among the inter-organ communication factors, muscle-secreted myokines can modulate the function and survival of pancreatic beta-cells. Using primary human myotubes from soleus, vastus lateralis and triceps brachii muscles, we report here that the impact of myokines on beta-cells depends on fiber types and their metabolic status. We show that Type I and type II primary myotubes present specific mRNA and myokine signatures as well as a different sensitivity to TNF-alpha induced insulin resistance. Finally, we show that angiogenin and osteoprotegerin are triceps specific myokines with beta-cell protective actions against proinflammatory cytokines. These results suggest that type I and type II muscles could impact insulin secretion and beta-cell mass differentially in type 2 diabetes through specific myokines secretion. Nature Publishing Group UK 2018-07-03 /pmc/articles/PMC6030123/ /pubmed/29968746 http://dx.doi.org/10.1038/s41598-018-28117-2 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Rutti, Sabine
Dusaulcy, Rodolphe
Hansen, Jakob S.
Howald, Cédric
Dermitzakis, Emmanouil T.
Pedersen, Bente K.
Pinget, Michel
Plomgaard, Peter
Bouzakri, Karim
Angiogenin and Osteoprotegerin are type II muscle specific myokines protecting pancreatic beta-cells against proinflammatory cytokines
title Angiogenin and Osteoprotegerin are type II muscle specific myokines protecting pancreatic beta-cells against proinflammatory cytokines
title_full Angiogenin and Osteoprotegerin are type II muscle specific myokines protecting pancreatic beta-cells against proinflammatory cytokines
title_fullStr Angiogenin and Osteoprotegerin are type II muscle specific myokines protecting pancreatic beta-cells against proinflammatory cytokines
title_full_unstemmed Angiogenin and Osteoprotegerin are type II muscle specific myokines protecting pancreatic beta-cells against proinflammatory cytokines
title_short Angiogenin and Osteoprotegerin are type II muscle specific myokines protecting pancreatic beta-cells against proinflammatory cytokines
title_sort angiogenin and osteoprotegerin are type ii muscle specific myokines protecting pancreatic beta-cells against proinflammatory cytokines
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030123/
https://www.ncbi.nlm.nih.gov/pubmed/29968746
http://dx.doi.org/10.1038/s41598-018-28117-2
work_keys_str_mv AT ruttisabine angiogeninandosteoprotegerinaretypeiimusclespecificmyokinesprotectingpancreaticbetacellsagainstproinflammatorycytokines
AT dusaulcyrodolphe angiogeninandosteoprotegerinaretypeiimusclespecificmyokinesprotectingpancreaticbetacellsagainstproinflammatorycytokines
AT hansenjakobs angiogeninandosteoprotegerinaretypeiimusclespecificmyokinesprotectingpancreaticbetacellsagainstproinflammatorycytokines
AT howaldcedric angiogeninandosteoprotegerinaretypeiimusclespecificmyokinesprotectingpancreaticbetacellsagainstproinflammatorycytokines
AT dermitzakisemmanouilt angiogeninandosteoprotegerinaretypeiimusclespecificmyokinesprotectingpancreaticbetacellsagainstproinflammatorycytokines
AT pedersenbentek angiogeninandosteoprotegerinaretypeiimusclespecificmyokinesprotectingpancreaticbetacellsagainstproinflammatorycytokines
AT pingetmichel angiogeninandosteoprotegerinaretypeiimusclespecificmyokinesprotectingpancreaticbetacellsagainstproinflammatorycytokines
AT plomgaardpeter angiogeninandosteoprotegerinaretypeiimusclespecificmyokinesprotectingpancreaticbetacellsagainstproinflammatorycytokines
AT bouzakrikarim angiogeninandosteoprotegerinaretypeiimusclespecificmyokinesprotectingpancreaticbetacellsagainstproinflammatorycytokines